Frank Pasqualone, SVP, CHIEF BUSINESS OFFICER at Theravance Biopharma, holds 1.00K shares in Enveric Biosciences (Ticker: ENVB), holds 429.78K shares in Theravance Biopharma (Ticker: TBPH), holds 20.00K shares in Innoviva (Ticker: INVA). Most recently, Frank Pasqualone Bought ― shares of Enveric Biosciences on Sep 19, 2023 for an estimated value of 2.14K.